Rosenwald Lindsay A MD
- SEC CIK
- 0000941841
No open-market purchases or sales filed in the past year.
Current role at each company
- DERM Journey Medical CorpDirectoras of Jun 26, 2026
- FBIO Fortress Biotech, Inc.PRESIDENT, CEO & CHAIRMANas of Mar 20, 2026
- CKPT Checkpoint Therapeutics, Inc.Directoras of May 30, 2025
- ATXI Avenue Therapeutics, Inc.Directoras of Sep 25, 2024
- MBIO Mustang Bio, Inc.Directoras of Jul 7, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rosenwald Lindsay A MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FBIO Fortress Biotech, Inc.
PRESIDENT, CEO & CHAIRMAN16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 (view filing) | Oct 21 | 3 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.70 | +$70.0K | +0.9%11.6M after | |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +5.00K | $0.56 | +$2.80K | 0.0%11.6M after | |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.68 | +$68.0K | +0.9%11.7M after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +2.40M | $0.84 | +$2.01M | +18.5%15.3M after | |
| Aug 21, 2023 (view filing) | Aug 17-18 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +20.0K | $10.55 | +$210.9K | +21.6%112.5K after | 2 lots |
| Sep 27, 2023 (view filing)8:20 AM ET | Sep 26 | 1 day | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.2833 | +$28.3K | +0.7%15.4M after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +1.57M | $1.70 | +$2.66M | +152.2%2.60M after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchase | +1.57M | $0.00 | $0 | –1.57M after | Derivative |
| Jan 9, 2024 (view filing) | Jan 5 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +50.0K | $2.38 | +$119.0K | +1.8%2.86M after | |
| May 20, 2024 (view filing) | May 16 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +10.0K | $1.76 | +$17.6K | +0.3%2.87M after |
DERM Journey Medical Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 (view filing) | Sep 6 | 2 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, par value $0.0001 per share | +100.0K | $2.23 | +$223.0K | +702.0%114.2K after | |
| Mar 25, 2024 (view filing) | Mar 22 | 3 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, $0.0001 par value | +20.0K | $3.40 | +$68.0K | +17.5%134.2K after | |
| Mar 27, 2024 (view filing) | Mar 25 | 2 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, $0.0001 par value | +10.0K | $3.04 | +$30.4K | +7.4%144.2K after |
ATXI Avenue Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | Rosenwald Lindsay A MDDirector | PPurchase | +348.7K | $0.72 | +$251.0K | +6,178.9%354.3K after |
MBIO Mustang Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 (view filing) | Mar 18-Sep 13, 2022 | 381 daysLate | Rosenwald Lindsay A MDDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +9.09K | $0.619 | +$5.63K | +3.1%299.2K after | 2 lots |